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Thyroid nodules occur frequently, are more 
common in women, and the incidence increases with 
age for both sexes. Clinically normal thyroid glands 
commonly contain nodules in autopsy series. In 
20- to 50-year-old females, as high as 50% of the 
thyroid glands are nodular, whereas in males the 
incidence approaches 30% (I). When the preva-
lence of clinically palpable thyroid nodules was the 
objective of the Framingham population researchers, 
Vander et al (2) detected nodules in 6.4% of females 
and 1.5% of males aged 30-50 years. Even with 
diligent, thorough examination of the neck, only 
about one tenth of pathologically nodular thyroid 
glands can be detected. However, the number of 
palpable nodules is significant, and determination of 
the pathology of the nodule or goiter, once found, 
rests with the patient's physician. Unfortunately, a 
detailed history and physical examination frequently 
does not provide all the necessary information 
needed to make a definite etiologic or pathologic 
diagnosis. Knowledge of the type of goiter is man-
datory for proper treatment of the various disorders 
of the thyroid gland. 
The various types or causes of goiters are shown 
in Table l. Goiters may be divided clinically into 
diffuse or nodular; hyperthyroid, euthyroid, or 
hypothyroid. It is readily apparent that several 
pathologic entities may be diffuse or nodular in addi-
tion to altering thyroid function. Hyperthyroid 
patients may have a diffuse goiter, solitary nodule, or 
a multinodular gland. Graves' disease usually pre-
sents no diagnostic problems, but, rarely, a toxic 
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diffuse goiter may be caused by excessive pituitary 
thyroid-stimulating hormone (TSH) from hypo-
thalamic thyrotropin-releasing hormone (TRH) 
stimulation or pituitary tumor. Subacute nonsup-
purative thyroiditis may be focal or diffuse and cause 
transitory hyperthyroidism. The hyperthyroid phase 
of this disease is associated with a low or blocked 
radioactive iodine uptake (RAIU) and usually a pain-
ful, hard gland. The hyperthyroid adenomatous 
goiter produces the usual findings of thyrotoxicosis 
and, clinically, a multinodular goiter. Evaluation of a 
toxic adenoma will be discussed later. 
Euthyroid diffuse goiters, with the exception of 
thyroiditis, represent compensatory enlargement of 
the gland in an attempt to maintain normal hormone 
production. Patients with dietary iodine deficiency 
have an elevated RAIU that is suppressible with 
supraphysiologic doses of thyroid hormone (our 
standard procedure is to give l 50µg daily of 
triiodothyronine for seven days). E'xcessive iodine in-
take is associated with a suppressed or blocked 
RAIU. Diffuse goiter from congenital thyroidal en-
zyme deficiency, that is, peroxidase deficiency, results 
in an initially elevated RAIU with discharge of 
radioiodine from the gland following potassium 
perchlorate administration. The early adenomatous 
goiter often feels diffuse rather than nodular. The 
RAI U usually is normal, but the scan often shows 
nonuniform distribution of radioactivity within the 
gland. Subacute thyroiditis may diffusely involve the 
gland, and the patient may be euthyroid when seen. 
Chronic thyroiditis (Hashimoto's thyroiditis) is a 
painless, firm goiter frequently with high titers of an-
tithyroid antibodies present in the serum. Any of the 
diffuse goiters may be accompanied by hypo-
thyroidism, but low thyroid function is more com-
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DIFFUSE 
Graves' Disease 
Excess TSH 
Thyroiditis 
TABLE I 
Types of Goiters 
HYPERTHYROID 
EUTHYROID 
Iodine Deficiency 
Iodine Excess 
,Enzymatic Defects* 
Adenomatous 
Thyroiditis* 
NODULAR 
Adenomatous 
Adenoma 
Thyroiditis 
<:arcinoma 
Aden om a 
Colloid Cyst 
Adenomatous 
Thyroiditis 
* May be associated with hypothyroidism 
manly seen with congenital enzymatic deficiency 
goiters and Hashimoto's thyroiditis. 
Patients with nodular goiter ( as mentioned 
earlier) may be hyperthyroid or, rarely, hypothyroid, 
but are usually euthyroid. The euthyroid patients 
with nodular goiter, and especially those with a 
solitary nodule, represent the greatest diagnostic 
problem, for thyroid carcinoma must always be con-
sidered and excluded. Since one cannot differentiate a 
benign from a malignant tumor with certainty by 
palpation alone, further diagnostic tests are indicated 
(Fig. 1). The thyroid scan will determine whether the 
nodule is functioning (Fig. 2) or nonfunctioning (Fig. 
3). The pathology of functioning (hot) and nonfunc-
tioning (cold) nodules is shown in Table 2. The 
demonstration of a hot nodule with scanning essen-
tially excludes the probability that the lesion is a car-
cinoma. However, if the nodule is cold, one can only 
make a statistical guess concerning the pathology. 
Further diagnostic work-up can be pursued prior to 
surgical exploration (Fig. 1). Nonfunctioning, 
solitary nodules may be separated into cystic and 
solid with ultrasonography, and recent reports (3, 4) 
suggest that cystic thyroid nodules represent 20% of 
cold nodules and are benign. Additional procedures 
have been performed in an attempt to non-invasively 
exclude thyroid carcinoma. Sonography (5), in addi-
tion to distinguishing cystic from solid lesions, 
demonstrates a characteristic echo pattern in 
malignancy that may prove to be diagnostic if sub-
stantiated by additional reports. Thyroid scanning of 
cold nodules with other radiopharmaceuticals such as 
67Ga-citrate (6) and 75Selenomethionine (7, 8) ·may be 
positive in cases of thyroid cancer, but false negatives 
( 67Ga) and false positives {75Se) are frequent. 
Thermography (9) has been tried, but the number 
of lesions studied are too few to reach any con-
clusions. According to an oral communication 
from J. Frable, MD, in January, 1975, thin-bore nee-
dle aspiration can yield a positive diagnosis of papif-
lary adenocarcinoma, but cannot differentiate fol-
licular adenoma from adenocarcinoma. I might sum 
up by saying that the solitary, nonfunctioning and es-
pecially the solid thyroid nodule is malignant until 
proven otherwise by surgical exploration, The results 
of sonography are exciting and promising, but 
further studies are indicated before the role of 
ultrasound can be established in the evaluation of 
thyroid nodules (Fig. 4). 
The thyroid nodule that concentrates radio-
iodine may be a follicular adenoma, adenomatous 
nodule, normal thyroid tissue such as a lingual thy-
roid, or residual hyperplastic thyroid tissue following 
a subtotal thyroidectomy. The triiodothyronine sup-
pression test will differentiate the autonomously func-
tioning thyroid nodule from other types of function-
ing nodules (Fig. 5). Treatment of suppressible 
functioning thyroid nodules with thyroid hormone 
results usually in no further enlargement and fre-
quently in disappearance clinically of the nodule. 
The typical autonomously functioning thyroid 
nodule is illustrated in Figure 2. Although the patient 
is euthyroid, the nodule has suppressed the function 
of the normal thyroid tissue and is not suppressible 
with administration of triiodothyronine (Cytomel®). 
Administration of thyroid-stimulating hormone, 10 
units daily for three days, may be used to 
demonstrate the presence of normal but suppressed 
thyroid tissue. Treatment with 25 millicuries of 
radioactive iodine resulted in ablation of the nodule, 
appearance of the previously suppressed normal 
thyroid gland, and continuation of a euthyroid state. 
EVALUATION OF THYROID NODU LES 
DI AG NO STI C APPRO ACH 
THYRO ID NODULE 
FUNCTIONl t..JG NON-FUNCTIONING 
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Fig. I-Sequential diagnostic approach in evaluation of thyroid 
nodules. 
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Fig. 2-Left. Functioning 4 X 3 cm right thyroid nodule with normal RAIU and serum free thyroxine concentration; no radioiodine 
uptake in area of left lobe. Center. Triiodothyronine (T-3) administration produced no decrease in RAIU or nodule uptake. Right. 
Following radioiodine treatment, nodule has been ablated; right and left lobes concentrate radioiodine; overall thyroid function remains 
normal. 
.. 
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Fig. 3-Nonfunctioning thyroid nodule in lower pole of right 
lobe. Pathologic diagnosis was follicular adenoma. 
The question arises, though, should a nontoxic, 
autonomously functioning nodule be treated at all? 
What is the natural history of a functioning follicular 
adenoma? There are case reports of nontoxic nodules 
progressing to toxic nodules which then require 
treatment because of the development of clinical 
hyperthyroidism. Such a course of events is shown 
in Figure 6. Patient W.W. first noted a goiter 15 years 
ago, but was advised that no treatment was necessary. 
In 1969, his protein-bound iodine (PBI) was normal , 
and his nodule had gradually increased in size. 
When seen in 1973, he was hyperthyroid. Treatment 
with radioiodine achieved a euthyroid state but little 
to no reduction in the size of the nodule. It can be 
assumed that he had an autonomously functioning 
nodule from the onset that progressed in size over the 
years, achieving a sufficient mass to produce ex-
cessive amounts of thyroid hormone and hyper-
thyroidism . 
TABLE 2 
Pathology of Thyroid Nodules 
FUNCTIONING NONFUNCTIONING 
HISTOLOGIC DIAGNOSIS No. PERCENT No. PERCENT 
Adenomatous 53 70 107 58 
Adenoma 11 15 31 17 
Carcinoma 0 0 24 13 
Hyperplasia 5 7 0 0 
Thyroiditis, Chronic 0 0 7 4 
Unclassified _§ 8 
-1.2. 8 
Total 75 184 
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EVALUATION OF THYROID NODULES 
APPROACH TO TREATMENT 
I 
NON-FUNCTIONING THYROID NODULE 
I SONOGRAPHY I 
CYSTIC ..... .,_ _ _._! __ -ii•• SOLID* 
Rx: ASPIRATION + Rx: SURGERY+ 
THYROID HORMONE THYROID HORMONE 
*FURTHER EVALUATION OF NON-FUNCTIONING, SOLID 
THYROID NODULE IS INVESTIGATIONAL (1975) 
Fig. 4-Role of sonography in therapeutic approach to nonfunc-
tioning thyroid nodules. 
Is this case the exception or the rule? Horst and 
associates ( 10) and later Ferraz et al (11) suggest that 
the natural history of a nontoxic but autonomously 
functioning thyroid nodule is one of progression to 
hyperthyroidism. They based their conclusions on 
data demonstrating toxic nodules being larger than 
nontoxic ones, and the rather continuous spectrum of 
functional activity from euthyroidism to overt 
hyperthyroidism. Similarly, Hamburger and Meier 
(12) noted that those patients who were hyperthyroid 
RAIU-5hr.-23% . 
F~e_e ! .:!!- 6.~_~g_f.dl 
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APPROACH TO TREATMENT 
I 
FUNCTIONING THYROID NODULE 
T3 SUPPRESSION TEST 
150µg/dx7d 
SUPPRESSIBLE ------NON-SUPPRESSIBLE 
Rx: THYROID HORMONE 1 
TOXIC NON-TOXIC 
Rx: 1311 Rx: 131 I 
SURGERY 
OBSERVATION 
Fig. 5-Diagnostic and therapeutic approach to functioning 
thyroid nodule. 
were older and had larger nodules than euthyroid 
patients with nonsuppressible functioning nodules. In 
their prospective study of 28 nontoxic patients with 
autonomously functioning nodules followed one to 
ten years (majority followed less than six years), none 
became hyperthyroid, but four glands increased in 
size. A retrospective study by McCormack and 
Sheline ( 13) revealed 1 out of 14 nontoxic untreated 
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Fig. 6-Left. Large 9 X 6 cm toxic nodule with high RAIU and serum free thyroxine concentration. Right. Establishment of normal 
function, but persistence of nodule following radioiodine treatment. 
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Fig. 7-Left. Functioning thyroid nodule in lower right lobe with partial suppression of the remainder of the gland. Right. Loss of function 
in outlined nodule. 
patients developed hyperthyroidism. The longest 
follow-up was 8 \/2 years with a mean of about 4 years. 
The available data suggest circumstantially that non-
toxic, autonomously functioning thyroid nodules 
progress to toxicity, but usually not within the first 
eight to ten years from the initial diagnosis. 
The next case (Fig. 7) illustrates the opposite 
natural history-spontaneous disappearance of func-
tion from a hot nodule. The initial scan shows a func-
tioning nodule with partial suppression of the 
remaining gland. Treatment with triiodothyronine, 
l 50µg daily for seven days, resulted in a RAIU of I%, 
and no specific therapy was instituted. The patient 
became concerned about the small but visible mass in 
her neck. When she returned nine months later, the 
nodule had lost its ability to take up radioiodine. 
Surgical exploration revealed a follicular adenoma. 
Our experience and that of others (10, 13) reveal 
that large doses of radioiodine (20-40 millicuries) are 
necessary to ablate autonomously functioning 
thyroid nodules, that euthyroid function is achieved, 
and that hypothyroidism does not develop following 
treatment when the normal thyroid tissue is protected 
by endogenous and/ or exogenous thyroid hormone. 
On occasion, a residual but nonfunctioning nodule 
may persist following radioiodine therapy. Surgery, 
although equally effective therapy (13), adds unneces-
sary additional cost and morbidity for the patient 
with an autonomously functioning thyroid nodule. 
In summary, functioning but suppressible 
thyroid nodules may be treated successfully with 
thyroid hormone (Fig. 5). Completely or partially 
autonomously functioning nodules are benign fol-
licular adenomas. This type of nodule may progress 
in size to produce hyperthyroidism or may lose its 
ability to concentrate iodine. Radioiodine is a safe, 
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efficient treatment for autonomously functioning 
thyroid nodules and should be considered the treat-
ment of choice. 
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